CIBC Private Wealth Group’s Corcept Therapeutics CORT Stock Holding History

CIBC Private Wealth Group’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$27.5K	Buy	791 +21	+3%	+$1.65K	﹤0.01%	2036
2025 Q3	$64K	Buy	770 +433	+128%	+$31.3K	﹤0.01%	1677
2025 Q2	$24.7K	Buy	337 +16	+5%	+$1.16K	﹤0.01%	1932
2025 Q1	$22.6K	Sell	321 -191	-37%	-$11.6K	﹤0.01%	1947
2024 Q4	$26.5K	Sell	512 -323	-39%	-$16.9K	﹤0.01%	1943
2024 Q3	$38.6K	Sell	835 -20	-2%	-$711	﹤0.01%	1868
2024 Q2	$25.2K	Sell	855 -220	-20%	-$6.03K	﹤0.01%	1947
2024 Q1	$27.7K	Buy	+1,075	New	+$25.4K	﹤0.01%	1913

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CIBC Private Wealth Group's CORT Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Corcept Therapeutics (CORT) stake by 2.7% in Q4 2025, buying an estimated $1.65K and bringing the position to 791 shares worth $27.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2036.

CIBC Private Wealth Group first reported a position in CORT in Q1 2024 and has held it in 8 quarters since. The position peaked at $64K in Q3 2025. 389 funds tracked by Wall St. Rank hold CORT as of Q4 2025.

CIBC Private Wealth Group held 791 shares of Corcept Therapeutics worth $27.5K as of Q4 2025.
CIBC Private Wealth Group bought 21 Corcept Therapeutics shares in Q4 2025, an estimated $1.65K.
Corcept Therapeutics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2036 holding.
CIBC Private Wealth Group first reported a position in Corcept Therapeutics in Q1 2024 and has held it in 8 quarters since.
CIBC Private Wealth Group's Corcept Therapeutics position peaked at $64K in Q3 2025.
389 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.